[Changes in thrombocytic hemostasis in patients with diabetic glomerulosclerosis].
Indices of thrombocytic hemostasis were determined in 40 patients with diabetic glomerulosclerosis. It was found that patients suffering of diabetic glomerulosclerosis with chronic renal insufficiency showed signs of hypercoagulemia while changes of the thrombocytic hemostasis become of diverse values. There was a high correlation of hemostasis changes and clinical manifestations of diabetes mellitus and diabetic glomerulosclerosis. Three tests are recommended for treatment choice: hemolysate-aggregation test, determination of soluble complexes of monomer fibrin and fibrin-splitting product.
Belitskaia
G A
GA
Lapchinskaia
I I
II
Donish
R M
RM
Ishchenko
V M
VM
Fedorova
N E
NE
Glebova
A N
AN
Kozlenko
V M
VM
Korobko
V F
VF
Sobolevskaia
N V
NV
D000328:Adult; D001792:Blood Platelets / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D003928:Diabetic Nephropathies / Q000097:blood*; D005260:Female; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010979:Platelet Function Tests
Izmeneniia trombotsitarnogo gemostaza u bol'nykh diabeticheskim glomerulosklerozom.